Dymedso
Medical Equipment ManufacturingUnited States2-10 Employees
The Frequencer® is a digitally controlled, non-invasive acoustic airway clearance device manufactured and marketed by Dymedso.
Innovative Product Dymedso's flagship product, the Frequencer®, offers a non-invasive acoustic airway clearance solution, appealing to healthcare providers seeking advanced, patient-friendly respiratory therapy devices.
Growing Market Presence Despite a small team, Dymedso is positioned in a niche market with potential to scale, especially as demand for innovative respiratory solutions increases worldwide.
Financial Opportunity With recent funding of 1.3 million dollars and revenue up to 1 million dollars, there is clear investor confidence that could support expansion efforts and sales growth targeting medical facilities.
Technology Integration Utilizing modern web technologies, Dymedso demonstrates a focus on digital engagement and potential for online marketing strategies to reach healthcare decision-makers efficiently.
Market Alignment Positioned alongside comparable medical equipment companies with modest revenues and small teams, Dymedso can target cost-conscious healthcare providers and clinics seeking innovative respiratory care devices.
Dymedso uses 8 technology products and services including W3 Total Cache, Cloudflare, JSON-LD, and more. Explore Dymedso's tech stack below.
| Dymedso Email Formats | Percentage |
| First.Last@dymedso.com | 50% |
| First.Last@dymedso.com | 50% |
Medical Equipment ManufacturingUnited States2-10 Employees
The Frequencer® is a digitally controlled, non-invasive acoustic airway clearance device manufactured and marketed by Dymedso.
Dymedso has raised a total of $1.3M of funding over 2 rounds. Their latest funding round was raised on Oct 01, 2020 in the amount of $1.3M.
Dymedso's revenue is estimated to be in the range of $1M
Dymedso has raised a total of $1.3M of funding over 2 rounds. Their latest funding round was raised on Oct 01, 2020 in the amount of $1.3M.
Dymedso's revenue is estimated to be in the range of $1M